Clinical features and oncological outcomes of intestinal cancers associated with ulcerative colitis and Crohns disease
Glycosuria contributes directly to improved glycemic control, while increased distal sodium delivery restores normal tubuloglomerular feedback, thereby lowering intraglomerular pressure, which is a key mechanism in slowing DKD progression [25,27]
receives funding from the European Research Council (ERC-CoG Trusted no.101044445), the German Research Foundation (DFG TRR296, TRR152, SFB1123 and GRK 2816/1) and the German Center for Diabetes Research (DZD e.V.)
Potential side effects may include:_ gastrointestinal upset (nausea, vomiting, diarrhea, abdominal bloating) reduced appetite hypoglycemia (low blood sugar when consumed excessively) general weakness and tiredness Do NOT use GLP-1 Booster Gummies if you: have known allergies or hypersensitivity to any ingredients in this formulation